ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
5,667.56
0.08%
US Tech 100
19,264.40
0.49%
Dow Jones
41,985.35
0.08%
Brent Oil
71.775
0.00%
Bitcoin
85,130.25
1.53%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Cue Biopharma Inc (CUE)

  7. Cue Biopharma Inc (CUE) News

CUE

Cue Biopharma (CUE)

Cue Biopharma Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:CUE
DateTimeSourceHeadlineSymbolCompany
03/21/20257:14PMEdgar (US Regulatory)Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:CUECue Biopharma Inc
03/12/20254:00PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:CUECue Biopharma Inc
03/12/20254:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CUECue Biopharma Inc
03/12/20254:00PMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:CUECue Biopharma Inc
01/03/20254:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CUECue Biopharma Inc
01/03/20254:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CUECue Biopharma Inc
11/29/20244:30PMGlobeNewswire Inc.Cue Biopharma Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:CUECue Biopharma Inc
11/29/20244:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CUECue Biopharma Inc
11/29/20244:00PMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:CUECue Biopharma Inc
11/25/20248:00AMGlobeNewswire Inc.Cue Biopharma to Participate in Fireside Discussion at the Piper Sandler 36th Annual Healthcare ConferenceNASDAQ:CUECue Biopharma Inc
11/14/20244:05PMGlobeNewswire Inc.Cue Biopharma Reports Third Quarter 2024 Financial Results and Recent Business HighlightsNASDAQ:CUECue Biopharma Inc
11/14/20244:00PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CUECue Biopharma Inc
11/14/20244:00PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:CUECue Biopharma Inc
11/14/20248:00AMGlobeNewswire Inc.Cue Biopharma Announces Strategic Organizational TransitionNASDAQ:CUECue Biopharma Inc
11/12/20248:00AMGlobeNewswire Inc.Cue Biopharma to Participate in Fireside Chat at the Stifel 2024 Healthcare ConferenceNASDAQ:CUECue Biopharma Inc
11/08/20241:30PMGlobeNewswire Inc.Cue Biopharma Presents Positive Updated Data from its Phase 1 Trials of CUE-101 and CUE-102 in Head and Neck Cancer and WT1 Positive Cancers at the SITC 39th Annual MeetingNASDAQ:CUECue Biopharma Inc
10/08/20244:00PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:CUECue Biopharma Inc
10/07/20245:07PMEdgar (US Regulatory)Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:CUECue Biopharma Inc
10/04/20244:00PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:CUECue Biopharma Inc
10/04/20249:00AMGlobeNewswire Inc.Cue Biopharma Announces Upcoming Scientific Presentations at the Society for Immunotherapy of Cancer’s (SITC) 39th Annual MeetingNASDAQ:CUECue Biopharma Inc
09/27/20244:17PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:CUECue Biopharma Inc
09/27/20244:05PMEdgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:CUECue Biopharma Inc
09/26/202411:26PMGlobeNewswire Inc.Cue Biopharma Announces Pricing of $12.0 Million Public OfferingNASDAQ:CUECue Biopharma Inc
09/26/202411:10PMGlobeNewswire Inc.Cue Biopharma Announces Proposed Public OfferingNASDAQ:CUECue Biopharma Inc
09/26/20244:32PMEdgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:CUECue Biopharma Inc
09/26/20244:27PMGlobeNewswire Inc.Cue Biopharma Announces Proposed Public OfferingNASDAQ:CUECue Biopharma Inc
09/10/20244:00PMEdgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:CUECue Biopharma Inc
09/09/20248:00AMGlobeNewswire Inc.Cue Biopharma Appoints Industry Veteran Lucinda Warren as Chief Business OfficerNASDAQ:CUECue Biopharma Inc
09/05/20244:00PMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:CUECue Biopharma Inc
09/05/20244:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CUECue Biopharma Inc
 Showing the most relevant articles for your search:NASDAQ:CUE

Your Recent History

USOTC
KKPNY
Royal KPN NV (PK)
NYSE
CNHI
CNH Industrial NV
LSE
IM23
Investec Bnk 26
NASDAQ
NAVI
Navient
NASDAQI
CDL
Compass EMP US Large Cap...
LSE
CGO
Contango
LSE
CPRI
Frk Cem Dbt Etf
BIT
F29838
Vontobel Financial Produ...
ASX
ARVOC
Artemis Resources
LSE
48VK
Marston's I.32
COIN
IHTUSD
I HOUSE TOKEN
USOTC
CSTAF
Constellation Acquisitio... (PK)
LSE
06LC
Citibank Hang U
LSE
78JA
Ashtead 27
COIN
ICXUSD
ICON
BIT
FAMAMW
Msci World Metals and Mi...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub
United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads